《2019年欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南》——聚焦生活方式和药物治疗
臧雁翔,李为民
摘要(Abstract)：
<正>冠状动脉疾病(coronary artery disease,CAD)在急性事件发生之前常常是"慢性"而"稳定"的,但潜在的疾病状态并不"稳定",典型表现为斑块破裂或糜烂造成急性动脉栓塞。因此,根据CAD自然病程,2019年欧洲心脏病学会(European Society of Cardiology,ESC)发布了《2019年ESC慢性冠状动脉综合征(chronic coronary syndrome,CCS)诊断和管理指南》(以下简称《2019年CCS指南》)[1],将其分为急性冠状动脉综合征(acute coronary syndrome,ACS)和CCS。《2019年CCS指南》更新了CCS
关键词(KeyWords)： 冠状动脉综合征;生活方式;药物治疗;欧洲心脏病学会;指南解读
基金项目(Foundation):
作者(Author): 臧雁翔,李为民
参考文献(References)：
- [1] Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J, 2019.[Epub ahead of print]
- [2] Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease:the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J, 2013, 34(38):2949-3003.
- [3] Hajek P, Phillips-Waller A, Przulj D, et al. A randomized trial of E-cigarettes versus nicotine-replacement therapy. N Engl J Med,2019,380(7):629-637.
- [4] Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS:the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology(ESC)and of the European Association for CardioThoracic Surgery(EACTS).Eur Heart J,2018,39(3):213-260.
- [5] Sorbets E, Fox KM, Elbez Y, et al. Long-term outcomes of chronic coronary syndrome worldwide:insights from the international CLARIFY registry.Eur Heart J,2019.[Epub ahead of print]
- [6] Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias:lipid modification to reduce cardiovascular risk.Eur Heart J,2019.[Epub ahead of print]
- [7] Mc Murray JJV, DeMets DL, Inzucchi SE, et al. The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure(DAPA-HF)trial:baseline characteristics.Eur J Heart Fail,2019.[Epub ahead of print]